These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8065408)

  • 1. Risks and benefits of antiarrhythmic therapy.
    Roden DM
    N Engl J Med; 1994 Sep; 331(12):785-91. PubMed ID: 8065408
    [No Abstract]   [Full Text] [Related]  

  • 2. [The pro-arrhythmic effects of anti-arrhythmia agents].
    Haverkamp W; Wichter T; Chen X; Hördt M; Willems S; Rotman B; Hindricks G; Kottkamp H; Borggrefe M; Breithardt G
    Z Kardiol; 1994; 83 Suppl 5():75-85. PubMed ID: 7846949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drugs, QT interval abnormalities and ventricular arrhythmias.
    Thomas SH
    Adverse Drug React Toxicol Rev; 1994; 13(2):77-102. PubMed ID: 7918900
    [No Abstract]   [Full Text] [Related]  

  • 4. Torsade de pointes with amiodarone in a patient with previous torsade during beta-receptor blockade.
    Skanes AC; Morton BC; Green MS; Tang AS
    Can J Cardiol; 1997 Apr; 13(4):383-6. PubMed ID: 9141970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
    Mason JW
    N Engl J Med; 1993 Aug; 329(7):452-8. PubMed ID: 8332150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What have clinical trials taught us about proarrhythmia?
    Skanes AC; Green MS
    Can J Cardiol; 1996 Apr; 12 Suppl B():20B-26B. PubMed ID: 8616725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes.
    Shah SA; Kluger J; White CM
    Pharmacotherapy; 2007 Sep; 27(9):1297-305. PubMed ID: 17723083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical evaluation of new anti-arrhythmia drugs after the CAST (Cardiac Arrhythmia Suppression Trial) study].
    Meinertz T; Zehender M; Hohnloser SH
    Z Kardiol; 1992; 81 Suppl 4():145-9. PubMed ID: 1290291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QT prolongation and development of torsades de pointes with the concomitant administration of oral erythromycin base and quinidine.
    Lin JC; Quasny HA
    Pharmacotherapy; 1997; 17(3):626-30. PubMed ID: 9165570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a need for new antiarrhythmic drugs?
    Roden DM
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():13-8. PubMed ID: 8734158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug induced arrhythmias].
    Usuda K
    Ryoikibetsu Shokogun Shirizu; 1996; (12):538-41. PubMed ID: 9047533
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiarrhythmic drugs: from mechanisms to clinical practice.
    Roden DM
    Heart; 2000 Sep; 84(3):339-46. PubMed ID: 10956304
    [No Abstract]   [Full Text] [Related]  

  • 13. Proarrhythmic complications of sotalol.
    Campbell TJ
    Aust N Z J Med; 1996 Apr; 26(2):147-8. PubMed ID: 8744609
    [No Abstract]   [Full Text] [Related]  

  • 14. Proarrhythmia, a serious complication of antiarrhythmic drugs.
    Podrid PJ
    Curr Cardiol Rep; 1999 Nov; 1(4):289-96. PubMed ID: 10980856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arrhythmogenic effects of anti-arrhythmia agents].
    Pfeiffer D; Rostock KJ; Rathgen K; Schirdewan A; Kleiner HJ
    Z Gesamte Inn Med; 1987 Jul; 42(14):390-4. PubMed ID: 3673134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-arrhythmia agents. Effectiveness, lack of effectiveness and pro-arrhythmia effects].
    Steinbeck G
    Internist (Berl); 1992 Oct; 33(10):663-9. PubMed ID: 1385349
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cardiac side effects of anti-arrhythmia agents].
    Pfeiffer D; Lüderitz B
    Internist (Berl); 1996 Jan; 37(1):53-9. PubMed ID: 8837828
    [No Abstract]   [Full Text] [Related]  

  • 18. [Combination therapy with anti-arrhythmia agents].
    Lüderitz B; Jung W; Manz M
    Med Klin (Munich); 1992 Sep; 87(9):465-8. PubMed ID: 1406484
    [No Abstract]   [Full Text] [Related]  

  • 19. [Combination anti-arrhythmia therapy].
    Manz M; Jung W; Lüderitz B
    Internist (Berl); 1993 May; 34(5):444-51. PubMed ID: 7685329
    [No Abstract]   [Full Text] [Related]  

  • 20. Sotalol-induced torsades de pointes in patients with renal failure.
    Dancey D; Wulffhart Z; McEwan P
    Can J Cardiol; 1997 Jan; 13(1):55-8. PubMed ID: 9039065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.